Light‐chain amyloid myopathy isolated to skeletal muscles: A case report

Toshihiro Matsukawa; Katsuki Eguchi; Ichizo Nishino; Kohei Okada; Kazuo Oshimi; Takuto Miyagishima

doi:10.1002/ccr3.3310

Clinical Case Reports (Dec 2020)

Light‐chain amyloid myopathy isolated to skeletal muscles: A case report

Toshihiro Matsukawa,
Katsuki Eguchi,
Ichizo Nishino,
Kohei Okada,
Kazuo Oshimi,
Takuto Miyagishima

Affiliations

Toshihiro Matsukawa: Department of Internal Medicine/Hematology Kushiro Rosai Hospital Kushiro Japan
Katsuki Eguchi: Department of Neurology Kushiro Rosai Hospital Kushiro Japan
Ichizo Nishino: Department of Neuromuscular Research National Institute of Neuroscience Tokyo Japan
Kohei Okada: Department of Internal Medicine/Hematology Kushiro Rosai Hospital Kushiro Japan
Kazuo Oshimi: Department of Internal Medicine/Hematology Kushiro Rosai Hospital Kushiro Japan
Takuto Miyagishima: Department of Internal Medicine/Hematology Kushiro Rosai Hospital Kushiro Japan

DOI: https://doi.org/10.1002/ccr3.3310
Journal volume & issue: Vol. 8, no. 12
pp. 2868 – 2872

Abstract

Read online

Abstract Isolated amyloidosis, especially of amyloid light‐chain type, is an infrequent disease. Systemic chemotherapy for light‐chain amyloidosis isolated to skeletal muscles plays a key role to reduce clonal plasma cells producing aberrant immunoglobulin.

Published in Clinical Case Reports

ISSN: 2050-0904 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Medicine (General)
Website: http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2050-0904

About the journal

Abstract

Keywords